Study Summary
This trial is testing a new cancer treatment, Pembrolizumab, in combination with radiosurgery for people with high-grade epidural disease of the spine.
- Cancer
- Epidural Spinal Tumors
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 6 Secondary · Reporting Duration: Every 2 months, up to 20 months
Trial Safety
Safety Progress
Side Effects for
Trial Design
1 Treatment Group
Stereotactic Body Radiotherapy and Pembrolizumab Treatment
1 of 1
Experimental Treatment
10 Total Participants · 1 Treatment Group
Primary Treatment: Stereotactic Body Radiation Therapy · No Placebo Group · Phase < 1
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 9 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
What is the participant count for this research project?
"Affirmative. According to information published on clinicaltrials.gov, this medical trial is still seeking applicants and was first posted online on March 28th 2022. The study requires 10 participants from a single testing centre as of May 11th 2022." - Anonymous Online Contributor
Is there currently an opportunity for people to join the research project?
"The trial is still open to patients, as noted on clinicaltrials.gov. This research was initially posted on March 28th 2022 and last revised on May 11th of the same year." - Anonymous Online Contributor